Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.

Kim WS, Oki Y, Kim SJ, Yoon SE, Ardeshna KM, Lin Y, Ruan J, Porcu P, Brammer JE, Jacobsen ED, Yoon DH, Suh C, Suarez F, Radford J, Budde LE, Kim JS, Bachy E, Lee HJ, Bollard CM, Jaccard A, Kang HJ, Inman S, Murray M, Combs KE, Lee DY, Advani R, Gunter KC, Rooney CM, Heslop HE

Open source

DOI: 10.1007/s00277-021-04558-0
Published: 2021 Oct
Container: Annals of hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00277-021-04558-0,
  title = {Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.},
  author = {Kim WS and Oki Y and Kim SJ and Yoon SE and Ardeshna KM and Lin Y and Ruan J and Porcu P and Brammer JE and Jacobsen ED and Yoon DH and Suh C and Suarez F and Radford J and Budde LE and Kim JS and Bachy E and Lee HJ and Bollard CM and Jaccard A and Kang HJ and Inman S and Murray M and Combs KE and Lee DY and Advani R and Gunter KC and Rooney CM and Heslop HE},
  year = {2021},
  journal = {Annals of hematology},
  doi = {10.1007/s00277-021-04558-0},
  url = {https://doi.org/10.1007/s00277-021-04558-0}
}

RIS

TY  - JOUR
TI  - Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
AU  - Kim WS
AU  - Oki Y
AU  - Kim SJ
AU  - Yoon SE
AU  - Ardeshna KM
AU  - Lin Y
AU  - Ruan J
AU  - Porcu P
AU  - Brammer JE
AU  - Jacobsen ED
AU  - Yoon DH
AU  - Suh C
AU  - Suarez F
AU  - Radford J
AU  - Budde LE
AU  - Kim JS
AU  - Bachy E
AU  - Lee HJ
AU  - Bollard CM
AU  - Jaccard A
AU  - Kang HJ
AU  - Inman S
AU  - Murray M
AU  - Combs KE
AU  - Lee DY
AU  - Advani R
AU  - Gunter KC
AU  - Rooney CM
AU  - Heslop HE
PY  - 2021
JO  - Annals of hematology
DO  - 10.1007/s00277-021-04558-0
UR  - https://doi.org/10.1007/s00277-021-04558-0
ER  -

APA

WS, K., Y, O., SJ, K., SE, Y., KM, A., Y, L., J, R., P, P., JE, B., ED, J., DH, Y., C, S., F, S., J, R., LE, B., JS, K., E, B., HJ, L., CM, B., A, J., HJ, K., S, I., M, M., KE, C., DY, L., R, A., KC, G., CM, R., & HE, H. (2021). Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.. Annals of hematology. https://doi.org/10.1007/s00277-021-04558-0

Source records

pubmed · retrieved 2026-09-25T19:23:09.111Z